Eliem Therapeutics agrees to acquire Tenet

Eliem Therapeutics has announced an agreement for the acquisition of development-stage private biotechnology company Tenet Medicines.

Apr 13, 2024 - 00:00

Eliem Therapeutics agrees to acquire Tenet

Eliem Therapeutics has announced an agreement for the acquisition of development-stage private biotechnology company Tenet Medicines.

Read the original article

Tags:

Previous Article

Fujifilm invests $1.2bn ramping up North Carolina facility

Novartis signs deal for Arvinas’ prostate cancer therapy

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Deka Biosciences secures $20m to advance product pipeline

Deka Biosciences secures $20m to advance product pipeline

Sep 29, 2023

NN-9440 by Inversago Pharma for Metabolic Syndrome: Lik...

Dec 4, 2023

STAT+: Pharmalittle: FDA grants full approval to Alzheimer’s drug; Sanders blocks NIH nominee over drug costs

STAT+: Pharmalittle: FDA grants full approval to Alzhei...

Jul 8, 2023